Cargando…

Effective and underprescribed: what about clozapine?

Detalles Bibliográficos
Autor principal:	Müller, Helge H. O.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	PAGEPress Publications, Pavia, Italy 2017
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5661131/ https://www.ncbi.nlm.nih.gov/pubmed/29142664 http://dx.doi.org/10.4081/mi.2017.7193

Ejemplares similares

Underprescribing vs underfilling to oral anticoagulation: An analysis of linked medical record and claims data for a nationwide sample of patients with atrial fibrillation
por: Guo, Jingchuan Serena, et al.
Publicado: (2022)

Review of withdrawal catatonia: what does this reveal about clozapine?
por: Lander, Matthew, et al.
Publicado: (2018)

41.2 WHAT DOES EPIDEMIOLOGICAL DATA TELL US ABOUT CLOZAPINE’S EFFECTIVENESS?
por: Tiihonen, Jari
Publicado: (2018)

An international clozapine titration guideline for clozapine: An opportunity for moving forward on personalizing clozapine treatment in India and other countries
por: de Leon, Jose
Publicado: (2022)

What about It?
Publicado: (1890)

Promoting safer clozapine dosing in the Americas
por: de Leon, Jose, et al.
Publicado: (2022)

What's new about Natsal-3?
por: Mercer, Catherine H, et al.
Publicado: (2014)

What to do about data?
por: Gollery, Martin
Publicado: (2011)

41.1 WHAT DO META-ANALYSES TELL US ABOUT CLOZAPINE’S EFFICACY AND EFFECTIVENESS FOR TREATMENT REFRACTORY SCHIZOPHRENIA?
por: Siskind, Dan, et al.
Publicado: (2018)

What's different about Nursing Open?
por: Watson, Roger
Publicado: (2015)

What to Do about Childhood Obesity?
por: Kharofa, Roohi, et al.
Publicado: (2019)

Prediabetes: what are we talking about?
por: Escalada San Martín, Javier
Publicado: (2021)

Neuro-COVID-19: What are we talking about?
por: El Otmani, H., et al.
Publicado: (2020)

What Is the Fuss about Integrins and the Tumor Microenvironment?
por: Eble, Johannes A., et al.
Publicado: (2019)

What is unique about learning health systems?
por: Friedman, Charles P.
Publicado: (2022)

What Surgeon Should Know about Probiotics
por: Kotzampassi, Katerina
Publicado: (2022)

Medical marijuana: what are we talking about?
por: Weber, César Augusto Trinta, et al.
Publicado: (2022)

What is New about Neuroanaesthesia?
por: Umamaheswara Rao, G S
Publicado: (2009)

Aducanumab: What about the Patient?
por: Petersen, Ronald C.
Publicado: (2021)

What We Know and What We Don't Know About Preventing Stroke
por: Burch, Druin
Publicado: (2014)

Thymic neuroendocrine neoplasms—what we know, what we don’t know, and what to do about it
por: Lang, Matthias, et al.
Publicado: (2023)

Has the world ceased to care about HIV? And what can we do about it?
por: Wainberg, Mark A, et al.
Publicado: (2015)

What we still don't know about AIDS
por: Robertson, Miranda
Publicado: (2009)

Racism in science: what can we do about it?
Publicado: (2020)

What hepatologists need to know about COVID-19?
por: Yapali, Suna
Publicado: (2020)

What's So False about a False Chord?
por: Sorrell, Vincent L.
Publicado: (2023)

What We Talk about When We Talk about Artificial Intelligence in Radiation Oncology
por: Cuccia, Francesco, et al.
Publicado: (2022)

Editorial: What is special about the gene?
por: Edgar, Andrew, et al.
Publicado: (2008)

What Does the Korean Medical Association Need to Talk About?
por: Park, Hyoung Wook
Publicado: (2014)

What we know about paracentesis induced circulatory dysfunction?
por: Kim, Jeong Han
Publicado: (2015)

Bronchiectasis, the Latest Eosinophilic Airway Disease: What about the Microbiome?
por: Singh, Dave, et al.
Publicado: (2022)

What Should Be Done About Bias and Misconduct in Clinical Trials?
por: Fairman, Kathleen A., et al.
Publicado: (2009)

The DREADD agonist clozapine N-oxide (CNO) is reverse-metabolized to clozapine and produces clozapine-like interoceptive stimulus effects in rats and mice
por: Manvich, Daniel F., et al.
Publicado: (2018)

Clozapine-related immunodeficiency: Implications for Parkinson's disease psychosis in the context of the COVID-19 pandemic
por: Aubignat, M.
Publicado: (2021)

Clozapine cessation
por: Ktari, H., et al.
Publicado: (2022)

Arterial Stiffness—What Do We Know about It and What Do We Expect from This Biomarker?
por: Reiner, Željko
Publicado: (2022)

What are Indian oral pathologists talking about?
por: Ranganathan, K
Publicado: (2017)

What’s so special about military veterans?
por: Greenberg, Neil
Publicado: (2014)

What can BDNF genotype tell us about our memory?
por: Diniz, Breno S.
Publicado: (2017)

What do biomarkers tell us about the pathogenesis of ankylosing spondylitis?
por: Maksymowych, Walter P
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_2gnivpgiuukfccrh6irvptueqh